One of the outcomes of the China’s Greater Bay Area initiative will be the creation of more mutual recognition of device regulatory approvals between mainland China and Hong Kong.
If a device is approved in Hong Kong – which still uses a system of voluntary approvals – it can also be sold in the Greater Bay Area of mainland China
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?